These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8180127
41. Identification of the rat homologue of KAI1 and its expression in Dunning rat prostate cancers. Suzuki H, Dong JT, Gao AC, Barrett JC, Isaacs JT. Prostate; 1998 Dec 01; 37(4):253-60. PubMed ID: 9831222 [Abstract] [Full Text] [Related]
42. Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C beta and eta mRNAs in the tumors. Doi S, Goldstein D, Hug H, Weinstein IB. Mol Carcinog; 1994 Dec 01; 11(4):197-203. PubMed ID: 7999261 [Abstract] [Full Text] [Related]
43. Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumors. Isaacs JT, Isaacs WB, Coffey DS. Cancer Res; 1979 Jul 01; 39(7 Pt 1):2652-9. PubMed ID: 445468 [Abstract] [Full Text] [Related]
44. Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants. Rubenstein M, Shaw MW, McKiel CF, Ray PS, Guinan PD. Cancer Res; 1987 Jan 01; 47(1):178-82. PubMed ID: 3491674 [Abstract] [Full Text] [Related]
45. Murine monoclonal antibodies reactive with a variety of androgen independent Dunning rat prostate adenocarcinoma sublines also reactive with human prostate adenocarcinoma. Tjota A, Lee MT, Isaacs JT, Kadohama N, Lee CL. J Urol; 1991 Jul 01; 146(1):205-12. PubMed ID: 2056591 [Abstract] [Full Text] [Related]
46. Association of elevated levels of protein kinase C-zeta mRNA and protein with murine B-lymphocytic neoplasia. Goodnight J, Mischak H, Mushinski JF. Mol Carcinog; 1994 Nov 01; 11(3):131-7. PubMed ID: 7945801 [Abstract] [Full Text] [Related]
47. Loss of protein kinase C delta isozyme immunoreactivity in human adenocarcinomas. Craven PA, DeRubertis FR. Dig Dis Sci; 1994 Mar 01; 39(3):481-9. PubMed ID: 8131683 [Abstract] [Full Text] [Related]
48. Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer. Yao S, Ireland SJ, Bee A, Beesley C, Forootan SS, Dodson A, Dickinson T, Gerard P, Lian LY, Risk JM, Smith P, Malki MI, Ke Y, Cooper CS, Gosden C, Foster CS. Br J Cancer; 2012 Jul 10; 107(2):388-99. PubMed ID: 22644296 [Abstract] [Full Text] [Related]
49. The cDNA sequence, expression pattern and protein characteristics of mouse protein kinase C-zeta. Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF, Mischak H. Gene; 1992 Dec 15; 122(2):305-11. PubMed ID: 1487145 [Abstract] [Full Text] [Related]
50. Developmental expression of the protein kinase C family in rat hippocampus. Jiang X, Naik MU, Hrabe J, Sacktor TC. Brain Res Dev Brain Res; 1994 Apr 15; 78(2):291-5. PubMed ID: 8026084 [Abstract] [Full Text] [Related]
51. Intermediate filament expression and the progression of prostatic cancer as studied in the Dunning R-3327 rat prostatic carcinoma system. Ramaekers FC, Verhagen AP, Isaacs JT, Feitz WF, Moesker O, Schaart G, Schalken JA, Vooijs GP. Prostate; 1989 Apr 15; 14(4):323-39. PubMed ID: 2664736 [Abstract] [Full Text] [Related]
52. Differential expression of protein kinase C isoforms in human colorectal cancers. Kuranami M, Powell CT, Hug H, Zeng Z, Cohen AM, Guillem JG. J Surg Res; 1995 Feb 15; 58(2):233-9. PubMed ID: 7861778 [Abstract] [Full Text] [Related]
53. Protein kinase M zeta synthesis from a brain mRNA encoding an independent protein kinase C zeta catalytic domain. Implications for the molecular mechanism of memory. Hernandez AI, Blace N, Crary JF, Serrano PA, Leitges M, Libien JM, Weinstein G, Tcherapanov A, Sacktor TC. J Biol Chem; 2003 Oct 10; 278(41):40305-16. PubMed ID: 12857744 [Abstract] [Full Text] [Related]
54. Adenylate kinase: an oncodevelopmental marker in an animal model for human prostatic cancer. Hall M, Mickey DD, Wenger AS, Silverman LM. Clin Chem; 1985 Oct 10; 31(10):1689-91. PubMed ID: 2994906 [Abstract] [Full Text] [Related]
55. Detection of protein kinase C subspecies expression at the mRNA level using a reverse transcriptase-polymerase chain reaction approach. Eastwood LM, Rumsby MG, McMorris FA. Biochem Soc Trans; 1993 Nov 10; 21(4):379S. PubMed ID: 8131956 [No Abstract] [Full Text] [Related]
57. Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Cornford P, Evans J, Dodson A, Parsons K, Woolfenden A, Neoptolemos J, Foster CS. Am J Pathol; 1999 Jan 10; 154(1):137-44. PubMed ID: 9916928 [Abstract] [Full Text] [Related]
58. Cell surface charge in predicting metastatic potential of aspirated cells from the Dunning rat prostatic adenocarcinoma model. Carter HB, Coffey DS. J Urol; 1988 Jul 10; 140(1):173-5. PubMed ID: 3379685 [Abstract] [Full Text] [Related]
60. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model. Doyle GM, Sharief Y, Mohler JL. J Urol; 1992 Feb 10; 147(2):514-8. PubMed ID: 1732634 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]